No Data
No Data
LaSalle Logi, Fujitec, etc. (added) Rating
Upgrade-Bullish Code | Stock Name | Securities Company | Conventional | After Change |------|---------|---------|<3466>|LaSalle Logi | Mizuho | “Neutral” | “Buy” |<5332>|TOTO | Mizuho | “Neutral” | “Neutral” | “Buy” |<5938>|LIXIL |GS
List of Unrivaled Stocks (Part 1) [Ichimoku Equilibrium Chart/Kumoku Stock List]
○Kumojo Stock List Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime <1976> Meisei Kogyo 1231 1230.5 1178.5 <5970> G-TEKT 2073 2014.25 1886.5 <6740> JDI 22 21.75 20 <7453> Good Product Plan 2338
List of Unrivaled Stocks (Part 2) [Ichimoku Equilibrium Chart/Kumoku Stock List]
○Kumo Stock List Market Code Stock Name Closing Price Preceding Span A Preceding Span B Tokyo Stock Exchange Prime <6258> Hirata Kiko 7190 7902.5 7230 <6273> SMC 82850 87072.5 83565 <6289> Giken Seisakusho 1989 2048.5 2009.5 <6298> wa
Convertible Stock List (Part 2) [Parabolic Signal Convertible Stock List]
○ List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime <1887> Japan Land Development 527 541 <2317> Cystena 259 267 <2389> Digital HD 1139 1205 <2429> World HD 2433 2588 <2432> DNA 1537
Astellas Pharmaceuticals, 24/3 revised downward operating profit 13 billion yen ← 83 billion yen
Astellas Pharmaceuticals <4503> announced revisions to its earnings forecast for the fiscal year ending 2024/3. Operating profit was revised downward from 83 billion yen to 13 billion yen. As a result of reviewing the asset value of the gene therapy program AT808, which is undergoing research and development for Friedreich ataxia patients, impairment losses of approximately 40 billion yen of intangible assets related to AT808 will be recorded as other expenses. [Positive Evaluation] <8233>Takashimaya Full Year | <6432>Takeuchi Production
Ryohin Keikaku's Attributable Profit Soars 114% in Fiscal H1
Ryohin Keikaku's (TYO:7453) profit attributable to owners of the parent surged 114.4% to 15.77 billion yen in the fiscal six months ended Feb. 29, from 7.36 billion yen a year ago mainly due to higher
No Data